Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. J Am Acad Dermatol. 2023 Feb 09.
View in:
PubMed
MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome. Cancers (Basel). 2023 Jan 06; 15(2).
View in:
PubMed
Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. Gastroenterology. 2023 01; 164(1):5-8.
View in:
PubMed
Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. Clin Gastroenterol Hepatol. 2023 01; 21(1):3-7.
View in:
PubMed
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines. Clin Gastroenterol Hepatol. 2023 03; 21(3):581-603.e33.
View in:
PubMed
Reply to S. Raoof. J Clin Oncol. 2023 02 10; 41(5):1147-1149.
View in:
PubMed
A validation of models for prediction of pathogenic variants in mismatch repair genes. Genet Med. 2022 10; 24(10):2155-2166.
View in:
PubMed
Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. J Clin Oncol. 2022 12 10; 40(35):4083-4094.
View in:
PubMed
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol. 2022 10 01; 40(28):3257-3266.
View in:
PubMed
Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews. Hered Cancer Clin Pract. 2022 Jun 10; 20(1):22.
View in:
PubMed
Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2022 06 01; 117(6):846-864.
View in:
PubMed
Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2022 06; 95(6):1025-1047.
View in:
PubMed
Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2022 06; 162(7):2063-2085.
View in:
PubMed
Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. Genet Med. 2022 06; 24(6):1196-1205.
View in:
PubMed
Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential. Br J Cancer. 2022 06; 126(11):1595-1603.
View in:
PubMed
Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precis Oncol. 2021; 5.
View in:
PubMed
Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs). JCO Precis Oncol. 2021 11; 5:808-816.
View in:
PubMed
Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. JAMA Oncol. 2021 Nov 01; 7(11):1664-1668.
View in:
PubMed
A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO. Br J Cancer. 2021 12; 125(12):1712-1717.
View in:
PubMed
Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Gastroenterology. 2022 03; 162(3):772-785.e4.
View in:
PubMed
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. Lancet Oncol. 2021 11; 22(11):1618-1631.
View in:
PubMed
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer Prev Res (Phila). 2021 11; 14(11):1021-1032.
View in:
PubMed
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Letter. Cancer Prev Res (Phila). 2021 10; 14(10):973-974.
View in:
PubMed
Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal. Clin Gastroenterol Hepatol. 2022 Nov; 20(11):2650-2652.e1.
View in:
PubMed
COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals. Pancreatology. 2021 Apr 20.
View in:
PubMed
Dye-Based Chromoendoscopy in Patients With Lynch Syndrome: An Individual Patient Data Meta-Analysis of Randomized Trials. Am J Gastroenterol. 2021 04; 116(4):825-828.
View in:
PubMed
Correction to: Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al. Fam Cancer. 2021 Apr; 20(2):123.
View in:
PubMed
Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al. Fam Cancer. 2021 04; 20(2):121-122.
View in:
PubMed
Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome. Gastroenterology. 2021 07; 161(1):143-150.e4.
View in:
PubMed
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population. Fam Cancer. 2022 04; 21(2):167-180.
View in:
PubMed
Dye-Based Chromoendoscopy in Patients With Lynch Syndrome: An Individual Patient Data Meta-Analysis of Randomized Trials. Am J Gastroenterol. 2021 Feb 11.
View in:
PubMed
Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer. JCO Oncol Pract. 2021 02; 17(2):e236-e247.
View in:
PubMed
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2020 Nov 04.
View in:
PubMed
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 11; 159(5):1916-1934.e2.
View in:
PubMed
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2020 11; 115(11):1751-1767.
View in:
PubMed
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2020 11; 92(5):997-1015.e1.
View in:
PubMed
Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing SMAD4/BMPR1A Variant. Cancer Prev Res (Phila). 2021 02; 14(2):215-222.
View in:
PubMed
Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing. J Clin Oncol. 2020 12 01; 38(34):4086-4094.
View in:
PubMed
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. N Engl J Med. 2020 09 10; 383(11):1028-1039.
View in:
PubMed
Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. Fam Cancer. 2021 04; 20(2):111-116.
View in:
PubMed
Endoscopic Removal of Colorectal Lesions: Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2020 03; 115(3):435-464.
View in:
PubMed
Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2020 03; 115(3):415-434.
View in:
PubMed
Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2020 03; 91(3):486-519.
View in:
PubMed
Spotlight: US Multi-Society Task Force on Colorectal Cancer Recommendations for Follow-up After Colonoscopy and Polypectomy. Gastroenterology. 2020 03; 158(4):1154.
View in:
PubMed
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors. Cancer Prev Res (Phila). 2020 03; 13(3):291-298.
View in:
PubMed
Spotlight: US Multi-Society Task Force on Colorectal Cancer Recommendations for Endoscopic Removal of Colorectal Lesions. Gastroenterology. 2020 03; 158(4):1130.
View in:
PubMed
Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 03; 158(4):1095-1129.
View in:
PubMed
Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020 03; 158(4):1131-1153.e5.
View in:
PubMed
Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2020 03; 91(3):463-485.e5.
View in:
PubMed
Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. Hered Cancer Clin Pract. 2019; 17:31.
View in:
PubMed
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020 01; 69(1):7-17.
View in:
PubMed
Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):193-199.
View in:
PubMed
Health behaviours and beliefs in individuals with familial pancreatic cancer. Fam Cancer. 2019 10; 18(4):457-464.
View in:
PubMed
A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene. PLoS Genet. 2019 08; 15(8):e1008344.
View in:
PubMed
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. Nat Genet. 2019 09; 51(9):1308-1314.
View in:
PubMed
Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome. Clin Gastroenterol Hepatol. 2020 04; 18(4):830-837.e1.
View in:
PubMed
Surveillance for pancreatic cancer in high-risk individuals. BJS Open. 2019 10; 3(5):656-665.
View in:
PubMed
Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting. Fam Cancer. 2019 07; 18(3):317-325.
View in:
PubMed
Recent advances in Lynch syndrome. Fam Cancer. 2019 04; 18(2):211-219.
View in:
PubMed
Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1175-1176.
View in:
PubMed
Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers. Fam Cancer. 2018 10; 17(4):567.
View in:
PubMed
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet Med. 2019 01; 21(1):213-223.
View in:
PubMed
Germline Genetic Testing for Pancreatic Ductal Adenocarcinoma at Time of Diagnosis. JAMA. 2018 06 19; 319(23):2383-2385.
View in:
PubMed
Precision Prevention and Early Detection of Cancer: Fundamental Principles. Cancer Discov. 2018 07; 8(7):803-811.
View in:
PubMed
Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews. Hered Cancer Clin Pract. 2018; 16:11.
View in:
PubMed
Relationship between individual and family characteristics and psychosocial factors in persons with familial pancreatic cancer. Psychooncology. 2018 07; 27(7):1711-1718.
View in:
PubMed
Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A. 2018 05 01; 115(18):4767-4772.
View in:
PubMed
Inherited DNA-Repair Defects in Colorectal Cancer. Am J Hum Genet. 2018 03 01; 102(3):401-414.
View in:
PubMed
Poor performance of clinical prediction models: the harm of commonly applied methods. J Clin Epidemiol. 2018 06; 98:133-143.
View in:
PubMed
Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer. 2017 07; 16(3):377-387.
View in:
PubMed
Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):49-58.
View in:
PubMed
Reply to M.S. Daniels et al. J Clin Oncol. 2017 08 01; 35(22):2588-2589.
View in:
PubMed
Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol. 2017 Jul 01; 35(19):2165-2172.
View in:
PubMed
Biallelic Mismatch Repair Deficiency: Management and Prevention of a Devastating Manifestation of the Lynch Syndrome. Gastroenterology. 2017 05; 152(6):1254-1257.
View in:
PubMed
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol. 2017 Mar; 36(2):115-127.
View in:
PubMed
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 01; 35(10):1086-1095.
View in:
PubMed
Comparison of Colonoscopy Quality Measures Across Various Practice Settings and the Impact of Performance Scorecards. Dig Dis Sci. 2017 04; 62(4):894-902.
View in:
PubMed
Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016 09 01; 122(17):2633-45.
View in:
PubMed
Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC). Carcinogenesis. 2016 08; 37(8):751-8.
View in:
PubMed
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study. Cancer Epidemiol Biomarkers Prev. 2016 07; 25(7):1185-91.
View in:
PubMed
Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer. J Oncol Pract. 2016 Mar; 12(3):e308-19, 259-60.
View in:
PubMed
Oncogastroenterology. J Clin Oncol. 2016 Apr 01; 34(10):1154-5.
View in:
PubMed
A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul; 84(1):115-125.e4.
View in:
PubMed
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov. 2016 Feb; 6(2):166-75.
View in:
PubMed
Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. J Natl Cancer Inst. 2016 Feb; 108(2).
View in:
PubMed
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. J Clin Oncol. 2015 Nov 01; 33(31):3660-7.
View in:
PubMed
Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. Cancer. 2015 Sep 15; 121(18):3281-9.
View in:
PubMed
Patient experiences living with pancreatic cancer risk. Hered Cancer Clin Pract. 2015; 13(1):13.
View in:
PubMed
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Gastroenterology. 2015 Sep; 149(3):604-13.e20.
View in:
PubMed
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015 May; 1(2):214-21.
View in:
PubMed
Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc. 2015 Nov; 82(5):812-8.
View in:
PubMed
Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. Genet Med. 2016 Feb; 18(2):152-61.
View in:
PubMed
PMS2 monoallelic mutation carriers: the known unknown. Genet Med. 2016 Jan; 18(1):13-9.
View in:
PubMed
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015 Feb; 110(2):223-62; quiz 263.
View in:
PubMed
Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing. Genet Med. 2015 Oct; 17(10):815-21.
View in:
PubMed
Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol. 2015 Apr; 84(4):575-80.
View in:
PubMed
Colorectal cancer in young adults. Dig Dis Sci. 2015 Mar; 60(3):722-33.
View in:
PubMed
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol. 2015 May; 13(5):963-9.e4.
View in:
PubMed
Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol. 2014 Dec; 150(12):1315-21.
View in:
PubMed
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015 Jul; 17(7):569-77.
View in:
PubMed
Changes in colorectal cancer screening intention among people aged 18-49 in the United States. BMC Public Health. 2014 Sep 01; 14:901.
View in:
PubMed
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2014 Aug; 147(2):502-26.
View in:
PubMed
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2014 Aug; 80(2):197-220.
View in:
PubMed
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum. 2014 Aug; 57(8):1025-48.
View in:
PubMed
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014 Aug; 109(8):1159-79.
View in:
PubMed
Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome. Surg Endosc. 2014 Aug; 28(8):2349-56.
View in:
PubMed
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol. 2014 Mar 10; 32(8):833-40.
View in:
PubMed
Therapy-associated polyposis as a late sequela of cancer treatment. Clin Gastroenterol Hepatol. 2014 Jun; 12(6):1046-50.
View in:
PubMed
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology. 2013 Oct; 145(4):775-81.e2.
View in:
PubMed
Prediction models in Lynch syndrome. Fam Cancer. 2013 Jun; 12(2):217-28.
View in:
PubMed
Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol. 2013 May 10; 31(14):1713-8.
View in:
PubMed
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol. 2013 Jun; 11(6):719-30.e5.
View in:
PubMed
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol. 2012 Dec; 127(3):544-51.
View in:
PubMed
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013 Jul; 62(7):1024-33.
View in:
PubMed
Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012 Aug 01; 308(5):485-492.
View in:
PubMed
Identification of germline genomic copy number variation in familial pancreatic cancer. Hum Genet. 2012 Sep; 131(9):1481-94.
View in:
PubMed
Knowledge of quality performance measures associated with endoscopy among gastroenterology trainees and the impact of a web-based intervention. Gastrointest Endosc. 2012 Jul; 76(1):100-6.e1-4.
View in:
PubMed
Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med. 2012 Jul; 14(7):670-80.
View in:
PubMed
Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol. 2012 Apr 01; 30(10):1024-7.
View in:
PubMed
Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut. 2013 Feb; 62(2):272-9.
View in:
PubMed
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila). 2012 Apr; 5(4):574-82.
View in:
PubMed
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012 Apr; 142(4):796-804; quiz e14-5.
View in:
PubMed
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2012 Jan; 2(1):41-6.
View in:
PubMed
Inherited colorectal cancer syndromes. Cancer J. 2011 Nov-Dec; 17(6):405-15.
View in:
PubMed
Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer. 2011 Sep; 10(3):549-56.
View in:
PubMed
An American founder mutation in MLH1. Int J Cancer. 2012 May 01; 130(9):2088-95.
View in:
PubMed
Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res. 2011 Oct 01; 17(19):6239-49.
View in:
PubMed
Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med. 2011 Jul; 13(7):651-7.
View in:
PubMed
Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011 Apr; 13(4):349-55.
View in:
PubMed
Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat. 2011 Apr; 32(4):407-14.
View in:
PubMed
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol. 2011 Jan; 12(1):49-55.
View in:
PubMed
Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila). 2011 Jan; 4(1):9-22.
View in:
PubMed
The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology. 2011 Jan; 140(1):73-81.
View in:
PubMed
Hereditary pancreatic cancer. Gastroenterology. 2010 Oct; 139(4):1076-80, 1080.e1-2.
View in:
PubMed
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol. 2010 Aug; 105(8):1851-60.
View in:
PubMed
Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2010 May; 138(5):1854-62.
View in:
PubMed
Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw. 2010 Jan; 8(1):98-105.
View in:
PubMed
Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark. 2010-2011; 8(2):109-12.
View in:
PubMed
Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009 Oct 28; 302(16):1790-5.
View in:
PubMed
Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009 Sep 01; 69(17):7053-61.
View in:
PubMed
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol. 2009 Aug 20; 27(24):3981-6.
View in:
PubMed
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009 Nov; 137(5):1621-7.
View in:
PubMed
Multivitamin use among multi-ethnic, low-income adults. Cancer Causes Control. 2009 Oct; 20(8):1271-80.
View in:
PubMed
Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol. 2009 Jun; 104(6):1508-18.
View in:
PubMed
Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome. Am J Surg Pathol. 2009 Feb; 33(2):309-12.
View in:
PubMed
Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol. 2009; 23(2):185-96.
View in:
PubMed
Colorectal cancer screening: prevalence among low-income groups with health insurance. Health Aff (Millwood). 2009 Jan-Feb; 28(1):169-77.
View in:
PubMed
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila). 2008 Dec; 1(7):507-13.
View in:
PubMed
Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Am J Gastroenterol. 2008 Nov; 103(11):2837-40.
View in:
PubMed
Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila). 2008 Nov; 1(6):470-5.
View in:
PubMed
Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology. 2009 Jan; 136(1):115-122.e1.
View in:
PubMed
Gastropericardial fistula-induced pericarditis: an unusual consequence of GERD. Medscape J Med. 2008; 10(9):205.
View in:
PubMed
Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA. 2008 Aug 27; 300(8):907-14.
View in:
PubMed
Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):2044-51.
View in:
PubMed
Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet. 2008 Sep; 45(9):557-63.
View in:
PubMed
Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol. 2008 Sep; 6(9):1004-10; quiz 955-.
View in:
PubMed
Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50. Cancer Causes Control. 2008 Dec; 19(10):1031-41.
View in:
PubMed
F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA. 2008 Mar 19; 299(11):1315-9.
View in:
PubMed
Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol. 2008 Mar; 6(3):333-8.
View in:
PubMed
Data reduction for prediction: a case study on robust coding of age and family history for the risk of having a genetic mutation. Stat Med. 2007 Dec 30; 26(30):5545-56.
View in:
PubMed
Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology. 2008 Jan; 134(1):39-46.
View in:
PubMed
Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol. 2007 Oct; 34(5):418-24.
View in:
PubMed
Linkage analysis of chromosome 4 in families with familial pancreatic cancer. Cancer Biol Ther. 2007 Mar; 6(3):320-3.
View in:
PubMed
Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol. 2007 Jun; 102(6):1284-90.
View in:
PubMed
The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007; 10(3):174-80.
View in:
PubMed
Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA. 2006 Sep 27; 296(12):1469-78.
View in:
PubMed
Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomarkers Prev. 2006 Jul; 15(7):1355-9.
View in:
PubMed
Detection of colorectal neoplasia associated K-Ras mutations in human urine. J Clin Oncol. 2006 Jun 20; 24(18_suppl):1005.
View in:
PubMed
Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2006 Apr; 15(4):704-10.
View in:
PubMed
Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer. 2006 Jan 15; 106(2):277-83.
View in:
PubMed
Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology. 2006 Jan; 130(1):73-9.
View in:
PubMed
Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):1022-8.
View in:
PubMed
Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol. 2005 Aug; 100(8):1821-7.
View in:
PubMed
Factors predicting willingness to participate in cancer genetic epidemiologic research. J Clin Oncol. 2005 Jun; 23(16_suppl):6007.
View in:
PubMed
Performance of the Revised Bethesda guidelines for identification of hereditary nonpolyposis colorectal cancer (HNPCC) mutation carriers. J Clin Oncol. 2005 Jun; 23(16_suppl):9506.
View in:
PubMed
Adenomas in young patients: what is the optimal evaluation? Am J Gastroenterol. 2005 May; 100(5):1150-3.
View in:
PubMed
Hereditary colorectal cancer syndromes. Cancer Causes Control. 2005 Apr; 16(3):201-13.
View in:
PubMed
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74.
View in:
PubMed
Surveillance of patients at high risk for colorectal cancer. Med Clin North Am. 2005 Jan; 89(1):61-84, vii-viii.
View in:
PubMed
Predictors of utilization of early colonoscopy vs. radiography for severe lower intestinal bleeding. Gastrointest Endosc. 2005 Jan; 61(1):46-52.
View in:
PubMed
Colon cancer screening strategies. Curr Opin Gastroenterol. 2005 Jan; 21(1):59-63.
View in:
PubMed
Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn. 2004 Nov; 6(4):386-95.
View in:
PubMed
Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med. 2004 Oct; 27(3):239-45.
View in:
PubMed
Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004 Sep 22; 292(12):1480-9.
View in:
PubMed
Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol. 2004 Sep; 2(9):813-9.
View in:
PubMed
The impact of family history of diabetes on glucose testing and counseling behavior in primary care. Diabetes Care. 2004 Sep; 27(9):2247-8.
View in:
PubMed
Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery. 2004 Jun; 135(6):683-9.
View in:
PubMed
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn. 2004 May; 6(2):101-7.
View in:
PubMed
Dysplasia in Barrett esophagus. Cancer. 2004 Apr 15; 100(8):1622-7.
View in:
PubMed
Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet. 2004 Apr; 41(4):e44.
View in:
PubMed
Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology. 2004 Mar; 126(3):936-7.
View in:
PubMed
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18; 96(4):261-8.
View in:
PubMed
Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis. J Natl Cancer Inst. 2004 Feb 04; 96(3):191-201.
View in:
PubMed
One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst. 2004 Jan 07; 96(1):2-3.
View in:
PubMed
Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol. 2003 Aug; 98(8):1875-80.
View in:
PubMed
Cancer surveillance is often inadequate in people at high risk for colorectal cancer. J Med Genet. 2003 May; 40(5):e54.
View in:
PubMed
Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med. 2003 Apr 14; 163(7):838-43.
View in:
PubMed
Timing of colonoscopy: impact on length of hospital stay in patients with acute lower intestinal bleeding. Am J Gastroenterol. 2003 Feb; 98(2):317-22.
View in:
PubMed
Genetic testing for hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol. 2003 Jan; 19(1):57-63.
View in:
PubMed
Colon cancer screening strategies. Curr Opin Gastroenterol. 2002 Sep; 18(5):595-601.
View in:
PubMed
A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 2002 Jul 15; 62(14):3925-8.
View in:
PubMed
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res. 2002 Jun 15; 62(12):3485-92.
View in:
PubMed
Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet. 2000 Sep; 37(9):641-5.
View in:
PubMed
Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA. 2000 Aug 16; 284(7):857-60.
View in:
PubMed
Hereditary nonpolyposis colorectal cancer: a call for attention. J Clin Oncol. 2000 Jun; 18(11):2189-92.
View in:
PubMed
Potential roles of genetic biomarkers in colorectal cancer chemoprevention. J Cell Biochem Suppl. 2000; 34:28-34.
View in:
PubMed
Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 1999 Oct 15; 59(20):5068-74.
View in:
PubMed
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA. 1999 Jul 21; 282(3):247-53.
View in:
PubMed
Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med. 1999 Mar 16; 130(6):471-7.
View in:
PubMed
Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15; 129(10):787-96.
View in:
PubMed
Ulcerative colitis and colon cancer: more controversy than clarity. Dig Dis. 1998 Mar-Apr; 16(2):81-7.
View in:
PubMed
Colorectal cancer in women: an underappreciated but preventable risk. J Womens Health. 1998 Feb; 7(1):45-8.
View in:
PubMed
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res. 1997 Nov 15; 57(22):5017-21.
View in:
PubMed
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum. 1995 Jan; 38(1):5-18.
View in:
PubMed